However, global overexpression of GPx1 induced obesity, hyperglycemia, insulin resistance in mice, and developed type 2 diabetes-like phenotypes (105–107), which infered adverse effects of excessive selenoprotein biosynthesis and the complexity of redox status. The gene discussed is GPX1; the disease is Hyperglycemia.